MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Inicio・Lista de Acciones・Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

Cerrado

SectorSalud

11.51 -1.54

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

11.37

Máximo

11.7

Métricas clave
By Trading Economics
Ingresos	-1.8M 22M
Ventas	7.5M 70M
P/B Media del Sector	26.326 37.257
Margen de beneficio	30.729
Empleados	130
EBITDA	6.3M 28M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	-0.34% downside

Dividendos
By Dow Jones
Próximas Ganancias	6 nov 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	289M 1.5B
Apertura anterior	13.05
Cierre anterior	11.51

Noticias sobre sentimiento de mercado

By Acuity

28%

72%

90 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

8.1 / 8.21 Soporte y Resistencia

Aurinia Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 oct 2025, 20:45 UTC

Ganancias

Costco Wholesale Sales Climb in September, Early October

8 oct 2025, 20:12 UTC

Principales Movimientos del Mercado

Adquisiciones, fusiones, absorciones

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 oct 2025, 16:39 UTC

Principales Movimientos del Mercado

Mining Shares Rise as Gold Prices Soar

8 oct 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 oct 2025, 23:43 UTC

Charlas de Mercado

Gold Falls on Possible Profit-Taking -- Market Talk

8 oct 2025, 23:18 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Finance Acquisition Using Internal Funds

8 oct 2025, 23:17 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 oct 2025, 23:16 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 oct 2025, 21:54 UTC

Charlas de Mercado

Ganancias

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 oct 2025, 21:30 UTC

Charlas de Mercado

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 oct 2025, 21:26 UTC

Charlas de Mercado

Ganancias

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 oct 2025, 19:15 UTC

Charlas de Mercado

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 oct 2025, 19:01 UTC

Charlas de Mercado

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 oct 2025, 18:47 UTC

Charlas de Mercado

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs Will Remain a Publicly Traded Co >TASK

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 oct 2025, 18:45 UTC

Adquisiciones, fusiones, absorciones

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 oct 2025, 18:07 UTC

Charlas de Mercado

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 oct 2025, 16:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Energy & Utilities Roundup: Market Talk

8 oct 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 oct 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 oct 2025, 15:57 UTC

Charlas de Mercado

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 oct 2025, 15:56 UTC

Charlas de Mercado

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 oct 2025, 15:53 UTC

Charlas de Mercado

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 oct 2025, 15:44 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 oct 2025, 15:44 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 oct 2025, 15:43 UTC

Adquisiciones, fusiones, absorciones

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 oct 2025, 15:42 UTC

Adquisiciones, fusiones, absorciones

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Comparación entre iguales

Cambio de precio

Aurinia Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

-0.34% caída

Estimación a 12 meses

Media 11.67 USD -0.34%

Máximo 17 USD

Mínimo 9 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Aurinia Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.1 / 8.21Soporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There is one bullish event.

Sentimiento

By Acuity

90 / 371 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.